SEC Tracker
Get the app

Yarrow Bioscience YARW

Bellevue Group AG reports 10.6% stake in Yarrow Bioscience

Ownership stake disclosure by Bellevue Group AG

Form
Schedule 13G
Filed
Importance
Routine
  1. 1,000,000 shares held
  2. 10.6% of class
  3. Bellevue and BAM AG reported

Written from the Schedule 13G on EDGAR. Check the filing before you rely on it.

Open in the appGet the appView on EDGAR

Get an email when Yarrow Bioscience files

Only major filings: results, leadership changes, listing notices and other major events, each with the plain-English summary when we have one or the key facts and the EDGAR link. Routine insider filings never email. Confirm once; unsubscribe in one click.

Similar companies

Companies of similar size in SIC 2834 and related industry codes: the same peer list as the financial tables.

  1. Rein Therapeutics RNTX public float $32M, Jun 30, 2025
  2. Insight Molecular Diagnostics IMDX public float $32M, Jun 30, 2025
  3. Kezar Life Sciences KZR public float $33M, Jun 30, 2025
  4. Provectus Biopharmaceuticals PVCT public float $31M, Jun 30, 2025
  5. Tempest Therapeutics TPST public float $30M, Jun 30, 2025